Target intelligence / Profile preview

N-acetyl-D-galactosamine 6-sulfate (GalNAc6S) (GalNAc6S)

Target
GalNAc6S
Molecular classification
Carbohydrate, Glycosaminoglycan component, Sulfated monosaccharide
01

Overview

N-acetyl-D-galactosamine 6-sulfate (GalNAc6S) is a specific sulfated sugar residue found within the polysaccharide chains of chondroitin-6-sulfate and keratan sulfate. These glycosaminoglycans are vital components of the extracellular matrix, particularly in cartilage, heart valves, and the cornea, where they contribute to structural integrity and cellular signaling (Source: PubMed, PMID: 24533101). Under normal physiological conditions, the enzyme N-acetylgalactosamine-6-sulfatase (GALNS) cleaves the sulfate group from this residue during the degradation of these large molecules. In patients with Mucopolysaccharidosis IVA, also known as Morquio A syndrome, a deficiency in GALNS leads to the systemic accumulation of GalNAc6S-containing glycosaminoglycans within lysosomes (Source: NIH, GARD). This accumulation causes progressive skeletal dysplasia, joint instability, and potential respiratory or cardiovascular complications. Therapeutic intervention involves enzyme replacement therapy with elosulfase alfa, a recombinant form of human GALNS that targets these accumulated residues to facilitate their breakdown and clearance (Source: FDA, Vimizim Prescribing Information).

Other names
GalNAc6SN-acetylgalactosamine-6-sulfateChondroitin-6-sulfate residueChondroitin sulfate C residue
02

Mechanism of action

Enzymatic hydrolysis of the sulfate ester bond at the C6 position of the N-acetylgalactosamine residue

03

Biological functions

Extracellular matrix organizationCartilage maintenanceSkeletal developmentCell signaling
04

Disease associations

Mucopolysaccharidosis IVAMorquio A syndromeSkeletal dysplasia
05

Safety considerations

Infusion-associated reactionsAnaphylaxisAnti-drug antibody formation
06

Interacting drugs

Elosulfase alfa
07

Biomarkers

Urinary keratan sulfateUrinary N-acetylgalactosamine 6-sulfate

Beyond the preview

Go deeper on N-acetyl-D-galactosamine 6-sulfate (GalNAc6S) (GalNAc6S).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-acetyl-D-galactosamine 6-sulfate (GalNAc6S) (GalNAc6S).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call